Department of Medicine 5 – Haematology and Oncology

Clinical significance of panendoscopy in initial staging of oral squamous cell carcinoma and detection of synchronous second malignancies of the upper aerodigestive tract — Insights from a retrospective population-based cohort study (2022) Spoerl S, Gerken M, Chamilos C, Spörl S, Fischer R, Vielsmeier V, Künzel J, et al. Journal article The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL. (2022) Rejeski K, Perez A, Iacoboni G, Penack O, Bucklein V, Jentzsch L, Mougiakakos D, et al. Journal article Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy (2022) Lammoglia Cobo MF, Welters C, Rosenberger L, Leisegang M, Dietze K, Pircher C, Penter L, et al. Journal article Krüppel-like factor 2 controls IgA plasma cell compartmentalization and IgA responses (2022) Wittner J, Schulz S, Steinmetz T, Berges J, Hauke M, Channell WM, Cunningham AF, et al. Journal article Physiological levels of 25-hydroxyvitamin D3 induce a suppressive CD4+ T cell phenotype not reflected in the epigenetic landscape (2022) Matos C, Renner K, Peuker A, Schoenhammer G, Schreiber L, Bruss C, Eder R, et al. Journal article Impact of spatially heterogeneous trop‐2 expression on prognosis in oral squamous cell carcinoma (2022) Erber R, Spoerl S, Mamilos A, Krupar R, Hartmann A, Rübner M, Taxis J, et al. Journal article Neutrophil extracellular traps drive epithelial‐mesenchymal transition of human colon cancer (2021) Stehr A, Wang G, Demmler R, Stemmler M, Straube J, Tripal P, Schmid B, et al. Journal article, Original article CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma (2021) Rejeski K, Perez A, Sesques P, Hoster E, Berger C, Jentzsch L, Mougiakakos D, et al. Journal article Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative (2021) Kayser S, Schlenk RF, Lebon D, Carre M, Goetze KS, Stoelzel F, Berceanu A, et al. Journal article BNT211: A phase I/II trial to evaluate safety and efficacy of CLDN6 CAR-T cells and CARVac-mediated in vivo expansion in patients with CLDN6+advanced solid tumors (2021) Haanen J, Mackensen A, Koenecke C, Alsdorf W, Desuki A, Wagner-Drouet E, Heudobler D, et al. Conference contribution